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CLINICAL SCIENCE
Optic disc morphology of patients with OPA1 autosomal
dominant optic atrophy
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Background/aims: Patients with autosomal dominant optic atrophy (ADOA) are genetically
heterogeneous, but all have disc pallor. A degree of cupping in ADOA can make the distinction from
normal tension glaucoma (NTG) clinically difficult. This study aimed to clarify the features of the optic
nerve of patients with ADOA at the OPA1 locus.
Methods: 29 patients (58 eyes), from 12 families, were identified in a prospective observational study
of patients with ADOA examined by a single observer between 1995 and 1998, in whom genetic
analysis showed either evidence for linkage to chromosome 3q28 or mutations in the ADOA gene,
OPA1. All of the patients had disc and fundal photographs available for retrospective analysis. Clini-
cal data collected included disc appearance, intraocular pressure, Snellen visual acuity, Hardy-Rand-
Rittler colour vision plates, and Humphrey 30-2 visual fields.
Results: Mean age at time of examination was 37 years and mean visual acuity was 6/24. Disc mor-
phology showed temporal disc pallor in 30 eyes (52%) and total disc pallor in 28 eyes (48%). At least
one disc showed a cup to disc ratio of more than 0.5 in 18 patients (28 discs, 48%). The temporal neu-
roretinal rim always showed pallor and shallow shelving (or saucerisation) was seen in 46 eyes (79%).
Only 12 discs (21%) had deep excavation and baring of blood vessels. All of the patients had normal
intraocular pressure and no family history of glaucoma. There was a temporal grey, pigmentary cres-
cent in 12 patients (18 eyes, 31%) and peripapillary atrophy in 20 patients (40 eyes, 69%), but disc
margin haemorrhages were not seen. There was no maculopathy or retinopathy.
Conclusion: The optic disc morphology, described for the first time in this genetically homogeneous
population of patients with OPA1 ADOA, shows a distinctive absence of a healthy neuroretinal rim and
shallow saucerisation of the optic disc cup, with frequent peripapillary atrophy.
Autosomal dominant optic atrophy (ADOA), Kjer type
1 is
an inherited primary optic neuropathy that leads to
reduced visual acuity. It presents with an insidious
onset of variable visual loss, optic nerve pallor, centrocaecal
visual field scotoma, and colour vision deficit.2 Histopathologi-
cal studies suggest that the underlying defect is due to retinal
ganglion cell degeneration. Genetic linkage studies localised a
dominant optic atrophy gene (OPA1; OMIM1655003) to
chromosome 3q28-qter,4 and we and others have identified the
OPA1 gene.5 6 It is a dynamin related GTPase5 6 which is widely
expressed, with high abundance in the retina. More than 66
mutations have been reported.5–11 These mutations include
missense and nonsense alterations, deletions, and insertions.
As over 50% of the mutations reported probably represent null
alleles, dominant inheritance of the disease may result from
haploinsufficiency of OPA1 protein, although there is also
some evidence for a pathophysiological dominant negative
effect.11 12 Analysis of the N-terminal leader peptide of the
deduced protein sequence suggests the OPA1 gene product is
targeted to mitochondria and may exert its function in
biogenesis and stabilisation of mitochondrial membrane
integrity. Thus, OPA1 ADOA may be due to impairment of
mitochondrial function caused by mutations in the nuclear
gene OPA1.
The optic nerve appearance in ADOA may range from
complete atrophy, through temporal pallor, to subtle pallor. We
previously described a clinical group of ADOA patients in whom
55% showed subtle or temporal pallor and 44% had total
atrophy of the optic nerve.13 The appearances of the optic disc
are usually symmetrical. Best colour vision and least field loss
have been noted in patients with the least degree of clinical
optic atrophy.13 The visual field defect in ADOA is centrocaecal,
central, or paracentral, and often appears as a large defect in
individuals with severe disease. The colour vision defect in
ADOA may be an acquired tritanopia,1 14 or a generalised
non-specific dyschromatopsia.15 Families with red-green colour
defects16–18 have been described. Our assessment of patients
from families that show evidence of linkage to the dominant
optic atrophy locus on chromosome 3q 28-qter has shown that
no patient examined displayed a truly isolated loss of tritan
discrimination,19 and what is more, there was even intrafamilial
variation in colour axis discrimination. Many patients show an
absent or delayed pattern visually evoked potential (PVEP),20
showing that there is a conduction defect in the optic nerve. The
pattern electroretinogram (PERG) shows an abnormal ratio of
waveforms (namely, the N95:P50 ratio), with reduction in the
amplitude of the N95 waveform.20–23 Since the PERG N95 com-
ponent is thought to be specific for the retinal ganglion cell,24
this finding supports a ganglion cell origin for ADOA.Magnetic
resonance imaging of the optic nerves in patients with
dominant optic atrophy shows a reduced optic nerve sheath
complex throughout the length of the intraorbital optic nerve
with no signal abnormality and a clearly visible cerebrospinal
fluid (CSF) space.25
There may be uncertainty in making the clinical diagnosis
in some patients, based solely on the appearance of the optic
disc. It is our experience that patients have occasionally been
misdiagnosed as suffering from Leber’s hereditary optic
neuropathy or normal tension glaucoma.
We undertook a detailed assessment of the disc appearances
in patients with ADOA in whom disc and fundal photographs
were available for retrospective analysis.All the selected patients
were from pedigrees in which either linkage analysis showed
evidence of linkage to chromosome 3q28 or which harboured
disease associated mutations in the ADOA gene,OPA1.11
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PATIENTS AND METHODS
Patient selection
Criteria for inclusion of patients in this study were (1)
availability of disc and fundal photographs for retrospective
analysis; (2) prospective clinical examination data by a single
observer; and (3) family data either showing linkage to chro-
mosome 3q28-qter markers or a documented mutation in the
OPA1 gene.
Clinical and photographic examination
Patients were identified from a prospective observational
study of patients with ADOA examined by a single observer
between 1995 and 1998. Probands from the families with
autosomal dominant optic atrophy were identified from the
Moorfields genetic clinic database. The clinical criteria for the
diagnosis of ADOA and inclusion of families in the study were
optic nerve pallor, reduced visual acuity, abnormal colour
vision, and a centrocaecal visual field defect in at least one
member of the family over 6 years of age, with evidence of
autosomal dominant inheritance. In addition to the prospec-
tive descriptions of the disc made by the single observer,
patients had disc and fundal photographs available for retro-
spective analysis.
Clinical data collected included disc appearance from clini-
cal examination and photographic survey, intraocular pres-
sure, Snellen visual acuity, Hardy-Rand-Rittler colour vision
plates, and Humphrey 30-2 visual fields.
The optic nerve was classified as either normal or showing
temporal pallor or total atrophy. The morphology of the optic
nerve was defined by cup:disc ratio, neuroretinal rim, excava-
tion, presence of a grey pigmentary crescent, and peripapillary
atrophy. The nerve fibre layer abnormalities visible with the
direct ophthalmoscope and the 90 dioptre (Volk aspheric) lens
with red-free light were noted. A number of patients had
scanning laser ophthalmoscopy imaging of the optic nerve
head and nerve fibre layer.
The study was approved by the ethics and scientific
committee of Moorfields Eye Hospital and written informed
consent was obtained prospectively from participants.
Genetic linkage analysis and OPA1 mutation detection
The documented OPA1 mutations in the patients included in
this study are reported in a separate publication.9 11 In
Figure 1 Twelve pedigrees with OPA1 ADOA described in this study. Solid symbol represents affected individual, open symbol represents
unaffected individual. Square = male; circle = female. Tangential line = deceased. *DNA sample analysed. ∼ clinical examination.
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summary, blood samples were taken and genomic DNA
extracted using the Nucleon II kit (Scotlab Bioscience; Strath-
clyde, Scotland, UK). PCR products were amplified from
patient DNA using primers located in flanking intron and UTR
sequences.7 All 28 coding exons of OPA1 and intron/exon splice
sites were screened for mutations by SSCP, heteroduplex
analysis and direct sequencing in one affected individual from
each family. Putative mutations were tested for segregation in
the respective families by SSCP/heteroduplex analysis or
direct sequencing, and in 100 control chromosomes (for
methods see Thiselton et al11).
RESULTS
Patients
Fifty eight patients from 12 pedigrees with linkage or
mutation data were identified (Fig 1), and of these clinical disc
photographs were available on 29 patients (50%). The
availability of disc photographs was apparently random, and
was chiefly determined by time of day at examination,
availability of photographer, and patient consent (Fig 2).
Where available the electrodiagnostic features and magnetic
resonance imaging of the optic nerve and chiasm have been
previously reported.20 25
Clinical profile
The mean age at time of examination was 37 years and mean
best corrected visual acuity was 6/24, with a spread from 6/9
to hand movements. There were 13 males and 16 females. The
mean age of onset of symptoms was 7 years, with a range of
2–25 years. Intraocular pressures were all within the normal
range (<21 mm Hg), with a range of 12–20 mm Hg
(mean 14.6 (SD 1.8) mm Hg). Colour vision, assessed by
Figure 2 Colour photographs of the optic discs of patients with autosomal dominant optic atrophy in this study illustrating key features: (A)
temporal pallor (pedigree B1: IV-15, right eye), (B) total atrophy (pedigree L1: V-2, right eye), (C) optic disc with CDR >0.5 (pedigree C5: II-3,
left eye), (D) temporal pigmentary crescent (pedigree T1: III-1, right eye), (E) and (F) peripapillary atrophy (pedigree H1: II-1. right (E) and (F)
left eyes).
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Hardy-Rand-Rittler colour plates for congenital and acquired
colour vision deficits showed a tritanopia in 28% (eight
patients) and a mixed deficit in 72% (21 patients). Humphrey
30-2 automated perimetry data were available in 24 patients.
They showed relative preservation of peripheral visual field in
all patients, a centrocaecal scotoma in 34 eyes (71%), and a
large central defect in 14 eyes (29%). The clinical features are
summarised in Table 1.
Of the 12 families, two had a history of affected individuals
who had been diagnosed as suffering from Leber’s hereditary
optic neuropathy in the past (F3: IV-2 and C7: II-3).
Optic nerve appearances
Disc morphology showed temporal disc pallor in 30 eyes (52%)
and total disc pallor in 28 eyes (48%). At least one disc showed
a cup to disc ratio of more than 0.5 in 18 patients (total of 28
discs, 48%). Temporal neuroretinal rim showed pallor in all
patients. Shallow shelving, or saucerisation, in at least the
temporal half of the disc was commonly observed (46 eyes,
79%) and only 12 discs (21%) had deep excavation and baring
of blood vessels. Overall, 28 discs (48%) had a cup to disc ratio
>0.5. All of these patients had normal intraocular pressure
and no family history of glaucoma. Red-free photographs
were available in six patients and qualitative red-free observa-
tional data was recorded for 19 patients. This showed a
thinned or absent retinal nerve fibre layer in the temporal
region, corresponding to the papillomacular bundle, in all
eyes. Five patients had recorded scanning laser ophthalmos-
copy images of the disc and macula. In these patients the NFL
was diffusely thinned, particularly in the temporal region of
the macula (data not shown), but none of these patients
showed a slit-like deficit, in contrast with findings in patients
with primary open angle glaucoma.26
There was a temporal pigmentary, or grey, crescent in 12
patients (18 eyes, 31%) and peripapillary atrophy in 20
patients (40 eyes, 69%). Disc margin haemorrhages were not
seen in any of the patients. There was no maculopathy or
retinopathy.
Chromosome 3q28-qter linkage data and OPA1
mutations
Table 1 shows the mutations in the individuals described in
this study,11 or linkage data to chromosome 3q28-qter. A
mutation in OPA1 in pedigree H1 was not detected by the
means used, but linkage analysis confirmed linkage to the
OPA1 locus (maximum Lod score of 3.91). The promoter
region of OPA1 has not characterised and was not therefore
screened, but further experiments to detect a mutation are
ongoing.
Genotype-phenotype correlation
No correlation was detected between the morphology of the
optic disc and the type of mutation in OPA1 or to the OPA1
protein domain which would be predicted to be affected. The
12 discs (21%) which showed deep excavation and the 28 discs
(48%) which had a cup to disc ratio >0.5 were found in
patients with OPA1 mutations throughout the gene.
DISCUSSION
This study of the optic disc and neuroretina in this group of 29
genetically homogeneous patients with OPA1 ADOA refines
the diagnostic criteria used in making the clinical diagnosis.
The patients described here are from 12 families who all show
either evidence of genetic linkage to chromosome 3q28 or who
have been shown to have mutations in the OPA1 gene. This is
the first reported study of the detailed features of the optic
disc in a genetically confirmed population of patients, who all
have OPA1 ADOA. Previous studies of disc excavation in
ADOA27 have been retrospective and have used a clinical defi-
nition of ADOA, but have not investigated or distinguished the
Table 1 Optic nerve features of 29 patients from 12 families with OPA1 ADOA in whom clinical examination data
and review of disc photographs were carried out
Pedigree
Mutation or
linkage
Location
in OPA1
gene:
Exon/
intron
Predicted
protein
domain
affected
Affected
individuals with
photographs
Mean
age at
exam
(years)
Age
range at
exam
(years)
Best VA
range
No of eyes
With
temporal
disc
pallor
With
total
disc
pallor
With
temporal
pigment
crescent
With
PPA
With
CDR>0.5
C5 Nonsense
Arg38stop
exon 7 Coiled coil II-3, III-3, III-4 24 12-45 6/18-6/
60
4 2 0 5 2
G1 Splice site
Skip exon 8
exon 8 Dynamin
related GTPase
III-7, III-9, III-10 31 28-34 6/9-6/
18
4 2 1 5 2
P1 Splice site
IVS9del(+1-5)
intron 9 V-2, V-3 30 26-34 6/9-
6/24
2 2 2 2 2
A1 Splice site
Skip exon 12
intron 12 III-12, IV-14, IV-15 12 2-28 6/12-4/
60
4 2 2 4 2
B1 Missense
Thr503Lys
exon 15 III-9, III-12, IV-13,
IV-15
52 23-68 6/
24-HM
4 4 2 5 4
L1 Missense
Thr503Lys
exon 15 V-2, V-5, VI-4 37 17-52 6/24-1/
60
4 2 3 3 4
K1 Deletion
Glu617fs
exon 20 Dynamin
central
IV-11, V-1, V-4 44 36-61 6/18-6/
60
4 2 3 6 3
T1 Deletion
Glu687fs
exon 21 III-1, IV-3 45 36-52 6/36-6/
60
0 4 1 2 2
B3 Deletion
Val902fs
exon 27 Coiled coil
C-terminal
III-1 31 NA 6/36 0 2 2 2 2
F3 Splice site
IVS27+6t>c/
IVS26-10c>g
intron 27 V-2 42 NA 6/18 0 2 0 2 1
C7 Deletion
Val902fs
exon 27 III-1 35 NA 6/18 2 0 0 0 0
H1 Lod score to
chromosome3
markers:
3.91
* II-1, III-2, III-3 34 24-52 6/18-6/
60
2 4 2 4 4
VA = visual acuity in Snellen. PPA = peripapillary atrophy. CDR = cup to disc ratio. *OPA1 mutation not detected on screening.
Putative protein domains OPA1- highly basic mitochondrial leader domain: exons 1-2. Coiled-coil domain 5b, 6, 7. GTPase domain: 8-15. Dynamin
central domain: 16-24. Coiled coil C-terminal: 27, 28.
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genetic aetiology of the optic atrophy. It is therefore possible
that patients with a dominant inheritance pattern of optic
atrophy, described in other studies, may have been genetically
heterogeneous. The visual defects reported in the one
published family with ADOA mapping to the locus OPA4
(chromosome 18q12.2–12.328) and the one reported family
mapping to OPA2 (Xp11.4-Xp11.229), overlap considerably
with that described for ADOA at the OPA1 locus.11 13 The recent
identification of mutations in the OPA3 gene found in a reces-
sive syndromic optic atrophy (optic atrophy plus syndrome, or
Costeff optic atrophy syndrome30), further demonstrate the
genetic heterogeneity that is possible in optic atrophy,
especially if a positive history of dominant inheritance is lack-
ing. In addition, it is increasingly recognised that normal ten-
sion glaucoma may be dominantly inherited.31 32 Therefore,
this study of a genetically homogeneous group of patients is
important for observations and conclusions about the
morphology of the optic disc in OPA1 ADOA.
The finding of pallor with disc excavation, in the absence of
raised intraocular pressure is a feature of a range of optic neu-
ropathies. These non-glaucomatous conditions include arter-
itic anterior ischaemic optic neuropathy, congenital optic
nerve anomalies such as coloboma,methanol toxicity, anterior
and posterior non-arteritic ischaemic optic neuropathy, optic
neuritis, traumatic and compressive optic neuropathies (for
example, tumours and aneurysms affecting the anterior visual
pathways).33 What appears to be most characteristic about the
optic disc in OPA1 ADOA is the absence of a healthy temporal
neuroretinal rim and the shelved appearance of the excava-
tion.
The universal finding of a grey, pigmented temporal
crescent within the neuroretinal rim tissue of the optic disc
was reported by Fournier et al27 in nine patients with dominant
optic atrophy. It is not clear what this morphological feature
may represent. We did not find a grey crescent universally in
this study. A grey crescent was clearly visible in 18 eyes (31%).
A grey, pigmentary crescent around the optic disc was first
described by Shields,34 who found that it was more common in
African-American patients (12% of normal patients in the
reported study) and in myopic patients. All of the patients
reported in this paper were white and the highest degree of
myopia was −1.25 dioptres.
Peripapillary atrophy in patients with ADOA was seen in
this study in 69% of eyes. A concordance of peripapillary cho-
rioretinal atrophy with visual field defects that accompany
glaucoma development has been noted in patients with ocular
hypertension.35 The extent and location of visual field
abnormalities that develop in hypertensive eyes with progres-
sion to glaucoma was found to exhibit a concordance with the
extent and location of progressive peripapillary atrophy noted
in the hypertensive.36
Neither the grey, pigmentary crescent nor peripapillary
atrophy are strictly correlated with the severity of the optic
disc pallor, although the data suggest that there may be a
trend to peripapillary atrophy with increased pallor of the disc.
ADOA caused by mutations in OPA1may be a mitochondrial
disease, albeit with still very little known of the actual mecha-
nisms of disease.5 6 Conservation between OPA1 and its yeast
orthologues, Msp1 in fission yeast37 and Mgm1 in budding
yeast,38 allows speculation regarding OPA1 pathophysiology
and its role in mitochondrial fusion and fission.39 The reported
histopathology documents that there is loss of retinal ganglion
cells, particularly from the papillomacular bundle and a thin-
ning of the optic nerve substance.40 41 There is also some loss of
myelin seen. This loss of myelin could be a primary or a
secondary event.42 However, a loss of myelin could lead to sec-
ondary changes in the pigmentation seen at the optic nerve
head. The chronic appearances of the optic nerve head in
ADOA are particularly difficult to distinguish from LHON
patients with remote visual loss.43 That the morphology of the
optic disc in these two conditions should be so strikingly simi-
lar is perhaps not surprising in view of some of the presumed
common underlying mitochondrial pathophysiological
mechanisms.
The importance of a clinical characterisation of the disc in
patients with OPA1 ADOA, and its distinction from the disc in
glaucoma, is highlighted by the report of the association
between two intragenic polymorphisms in the OPA1 gene and
normal tension glaucoma (NTG).44 It remains to be seen if the
clinical phenotype of NTG patients with these associated
polymorphisms is in any way distinct to those NTG patients
who do not appear to carry these polymorphisms or from
patients with primary open angle glaucoma. However, what is
emerging is the possibility that OPA1, and other genes that are
now being identified (for example, optineurin OPTN45), may
have a role in NTG, possibly as modifier genes.46 Despite con-
siderable similarity, it appears that the disc in OPA1 ADOA is
usually distinguishable from that of NTG, although the role of
the OPA1 gene in NTG remains to be clarified.
In conclusion, we have described, for the first time, features
of the optic disc in patients with ADOA at the OPA1 locus. This
may be useful for future studies of phenotype-genotype corre-
lation of the disc in optic neuropathy, including the
glaucomas, especially if more genes are found that may influ-
ence or modify the glaucoma phenotype. In the long term,
continued careful clinical dissection of phenotypes will help to
further our understanding of the pathophysiology of atrophy
of the optic nerve. The findings of this study suggest that the
disc appearance in ADOA differs from NTG chiefly by the
shallow shelving. However, there is clearly some overlap. An
early age of onset, with a family history and additional clini-
cal features of colour vision deficit, central field involvement
with sparing of the peripheral visual field, are important in
confirming the diagnosis of ADOA and distinguishing this disc
appearance from that of normal tension glaucoma.
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